Prospective clinical trials have demonstrated the safety and efficacy of active surveillance for men with localized prostate cancer, but also suggested that inadequate surveillance may risk missing an opportunity for cure.
Penile squamous cell carcinoma (PSCC) is rare with limited treatment options. We report the first whole exome sequencing analysis and compare the molecular landscape of PSCC to other SCCs, with the goal to identify common novel targets.
To evaluate factors associated with radical cystectomy (RC) refusal, subsequent treatment decisions, and their influence on overall survival (OS). We queried the National Cancer Database for patients with non-metastatic muscle-invasive bladder cancer (MIBC), cT2-T4M0.
Alicia Morgans: Hi. My name is Alicia Morgans, and I am a GU medical oncologist and Associate Professor of Medicine at Northwestern University. I am so excited to have here with me today, a friend and colleague, Dr. Tanya Dorff, who is the GU Division Chief at City of Hope and an Associate Professor of […]
A retrospective analysis of 354 patients, who underwent radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC) from 10 urology centers between 2005 and 2019, was performed to evaluate the effect of diagnostic ureterorenoscopy (URS) prior to RNU on intravesical recurrence (IVR) in patients with primary UTUC.
The incidence of kidney cancer is increasing and it could be counteracted with new ways to predict and detect it. Our work has the aim to implement an artificial neural network in order to predict the new cases of renal cell carcinoma in the population starting from population rate, obesity, smoking incidence, uncontrolled hypertension, and […]
Background – To investigate the effect of frailty on short-term postoperative outcomes in patients with prostate cancer treated with radical prostatectomy (RP). Methods – Within the National Inpatient Sample database, we identified 91,618 RP patients treated between 2008 and 2015. The Johns Hopkins Adjusted Clinical Groups frailty-defining indicator was applied, and we examined the rates […]
The majority of urologists performing radical prostatectomy in developed populations are doing so with robotic platforms. Since adopting this approach, many of us have observed that our patients appear to have less pain and recover more rapidly. If we are brutally honest with ourselves, we have all probably lowered our bar for accepting patients for […]
Prostate cancer is the leading cancer diagnosis among men in the United States with an estimated 248,530 new cases expected and is the second most common cause of cancer death for men in the United States, responsible for an estimated 34,130 deaths in 2021.1 It is a heterogeneous disease with locoregional cancers carrying an excellent […]
A new subclassification of the Pi-RADS 3 lesions was recently published and two subgroups have been suggested: 3a (indolent or low-risk lesions with volume <0.5 ml) and 3b (significant or high-risk lesions with volume ≥0.5 ml).1
